Disulfiram, an option for the treatment of pathological gambling?

Alcohol and Alcoholism

Volumn 45, Issue 2, 2010, Pages 214-216

  Mutschler, Jochen ^a,c   Bühler, Mira ^a   Grosshans, Martin ^a   Diehl, Alexander ^b   Mann, Karl ^a   Kiefer, Falk ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b KLINIKUM BRAUNSCHWEIG   (Germany)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; DISULFIRAM;

ADULT; ALCOHOL ABSTINENCE; ALCOHOLISM; ARTICLE; BEHAVIOR THERAPY; CASE REPORT; COMORBIDITY; DETOXIFICATION; DRUG TOLERABILITY; FATIGUE; HUMAN; LONG TERM CARE; MALE; PATHOLOGICAL GAMBLING; PRIORITY JOURNAL; RESIDENTIAL CARE; SELF HELP; WITHDRAWAL SYNDROME;

ALCOHOL DETERRENTS; ALCOHOLISM; BEHAVIOR THERAPY; COMBINED MODALITY THERAPY; COMORBIDITY; DISULFIRAM; FOLLOW-UP STUDIES; GAMBLING; HUMANS; IMPULSE CONTROL DISORDERS; MALE; MIDDLE AGED; RECURRENCE; REHABILITATION CENTERS; TEMPERANCE;

EID: 77949416468     PISSN: 07350414     EISSN: 14643502     Source Type: Journal    
DOI: 10.1093/alcalc/agp093     Document Type: Article

References (29)

1. Brewer C. (1990) Combining pharmacological antagonists and behavioural psychotherapy in treating addictions. Why it is effective but unpopular. Br J Psychiatry 157:34-40.
2. Brewer C. (1993) Recent developments in disulfiram treatment. Alcohol Alcohol 28:383-95.
3. Carroll KM, Fenton LR, Ball A et al. (2004) Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial. Arch Gen Psychiatry 61:264-72.
4. Cvek B, Dvorak Z. (2008) The value of proteasome inhibition in cancer. Can the old drug, disulfiram, have a bright new future as a novel proteasome inhibitor? Drug Discov Today 13:716-22.
5. de Sousa A, de Sousa A. (2004) A one-year pragmatic trial of naltrexone vs disulfiram in the treatment of alcohol dependence. Alcohol Alcohol 6:528-31.
6. de Sousa A, de Sousa A. (2005) An open randomized study comparing disulfiram and acamprosate in the treatment of alcohol dependence. Alcohol Alcohol 40:545-8.
7. Gossop M, Carroll KM. (2006) Disulfiram, cocaine, and alcohol: two outcomes for the price of one? Alcohol Alcohol 41:119-20.
8. Goudriaan AE, Oosterlaan J, De Beurs E et al. (2004) Pathological gambling: a comprehensive review of biobehavioral findings. Neurosci Biobehav Rev 28:123-41.
9. Grant JE, Kim SW, Odlaug BL. (2007) N-Acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study. Biol Psychiatry 62:652-7.
10. Grant JE, Potenza MN, Hollander E et al. (2006) Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am J Psychiatry 163:303-12.
11. Hall GW, Carriero NJ, Takushi RY et al. (2000) Pathological gambling among cocaine-dependent outpatients. Am J Psychiatry 157:1127-33.
12. Hollander E, Pallanti S, Allen A et al. (2005) Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders? Am J Psychiatry 162:137-45.
13. Kim SW, Grant JE, Adson DE et al. (2001) Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry 49:914-21.
14. Laaksonen E, Koski-Jannes A, Salaspuro M et al. (2009) A randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence. Alcohol Alcohol 43:53-61.
15. McCormick RA, Russo AM, Ramirez LF et al. (1984) Affective disorders among pathological gamblers seeking treatment. Am J Psychiatry 141:215-8.
16. Meyer G, Schwertfeger J, Exton MS et al. (2004) Neuroendocrine response to casino gambling in problem gamblers. Psychoneuroendocrinology 29:1272-80.
17. Mutschler J, Bühler M, Diehl A et al. (2009a) Disulfiram, an old drug with new potential in the treatment of pathological gambling? Med Hypotheses Electronic publication ahead of print.
18. Mutschler J, Diehl A, Kiefer F. (2009b) Pronounced paranoia as a result of cocaine-disulfiram interaction: case report and mode of action. J Clin Psychopharmacol 29:99-101.
19. Oakley-Browne MA, Adams P, Mobberley PM. (2000) Interventions for pathological gambling. Cochrane Database Syst Rev 18:1521.
20. Pallesen S, Molde H, Arnestad HM et al. (2007) Outcome of pharmacological treatments of pathological gambling: a review and meta-analysis. J Clin Psychopharmacol 27:357-64.
21. Potenza MN. (2006) Should addictive disorders include nonsubstance-related conditions? Addiction 101:1142-51.
22. Potenza MN. (2008) The neurobiology of pathological gambling and drug addiction: an overview and new findings. Philos Trans R Soc Lond B Biol Sci 363:3181-9.
23. Potenza MN, Kosten TR, Rounsaville BJ. (2001) Pathological gambling. JAMA 286:141-4.
24. Reuter J, Raedler T, Rose M et al. (2005) Pathological gambling is linked to reduced activation of the mesolimbic reward system. Nat Neurosci 8:147-8.
25. Roy A, Adinoff B, Roehrich L et al. (1988) Pathological gambling. A psychobiological study. Arch Gen Psychiatry 45:369-73.
26. Suh JJ, Pettinati HM, Kampman K et al. (2006) The status of disulfiram: a half of a century later. J Clin Psychopharmacol 26:290-302.
27. Tamminga CA, Nestler EJ. (2006) Pathological gambling: focusing on the addiction. Am J Psychiatry 163:180-1.
28. Weinshenker D, Schroeder JP. (2007) There and back again: a tale of norepinephrine and drug addiction. Neuropsychopharmacology 32:1433-51.
29. Wölfling K, Bühler M, Lemenager T et al. (2009) Gambling and internet addiction: review and research agenda. Nervenarzt 80: 1030-9.